IBI Feature: Accelerating Drug Discovery for Diseases of Ageing: In Vivo High Throughput Screening With C. elegans
IBI Feature: Accelerating Drug Discovery for Diseases of Ageing: In Vivo High Throughput Screening With C. elegans
Magnitude Biosciences Podcast Ep 1 | Dr Alex Parker: Screening probiotics to treat ALS with worms
Delaying Forgetting - How Ice and Lithium Affect Memory in C. elegans
Slowing Age-Dependant Mobility Decline with Timut Pepper
Welcome back to "The Nematode Corner" where we explore the fascinating world of Caenorhabditis elegans, or C. elegans, and its pivotal role in scientific research. In our previous posts, we've delved into the diverse ways this unassuming roundworm has influenced fields such as genetics, neurobiology, and drug development. Today, we venture into a different realm: […]
Brochure: Health & Nutrition - read and download the brochure
A couple of weeks ago we attended Probiota 2024 in Milan, a global meeting to discuss the science and the state of the probiotics market. The conference had many interesting scientific discussions, but what really piqued our interest were the insights shared by professionals in the marketing sector. One key takeaway stood out: the importance […]
GeroState Alpha is a pharmaceutical company, based at the Buck Institute for Research on Ageing in Novato, California, US. Their key therapeutic focus is on treating ageing and age-related disease. They needed to test their lead compounds to establish which was most effective at promoting health and slowing ageing. Magnitude Biosciences worked with Gerostate Alpha […]
Publication: New tools to monitor Pseudomonas aeruginosa infection and biofilms in vivo in C. elegans
© 2025 Magnitude Biosciences Ltd. All rights reserved.